Modulation of the antimicrobial content of myxobacteria outer membrane vesicles in response to varying LPS polysaccharide structures.

Information

  • Research Project
  • 10165749
  • ApplicationId
    10165749
  • Core Project Number
    P20GM130460
  • Full Project Number
    5P20GM130460-02
  • Serial Number
    130460
  • FOA Number
    PAR-18-266
  • Sub Project Id
    7934
  • Project Start Date
    5/15/2020 - 4 years ago
  • Project End Date
    3/31/2025 - 4 months from now
  • Program Officer Name
  • Budget Start Date
    4/1/2021 - 3 years ago
  • Budget End Date
    3/31/2022 - 2 years ago
  • Fiscal Year
    2021
  • Support Year
    02
  • Suffix
  • Award Notice Date
    4/13/2021 - 3 years ago

Modulation of the antimicrobial content of myxobacteria outer membrane vesicles in response to varying LPS polysaccharide structures.

Project Summary The 30-year absence of a newly discovered clinically approved natural product-derived antibiotic demonstrates the dire need for unique methods to access new antimicrobial scaffolds and activities. However, the recent surge in scrutiny of microbial genomes provides evidence to indicate that an abundance of chemical scaffolds hidden within nascent biosynthetic pathways (BSPs) remain undiscovered. Predatory myxobacteria have contributed over 600 distinct natural products to the microbial chemical space including 42 novel scaffolds of which 29 exhibit antibacterial or antifungal activities in the last 6 years alone. Myxobacteria exemplify the abundance of untapped chemical space with large bacterial genomes replete with BSPs that typically account for 10% of their total genomic content. However, unlike natural product isolations from other organisms such as plants or marine sponges sequestered directly from competitive surroundings, bacterial extracts from natural environments both marine and terrestrial often omit chemical entities below current detection levels. Instead, bacterial natural products are predominately isolated from axenic cultivation of a producing species removed from community maintenance and competition. We hypothesize that myxobacterial cultivation conditions that induce predation either through supplementation with isolated exopolysaccharide (EPS) from prey bacteria or non-axenic, co- cultivation with known quarry will result in production of antimicrobial new chemical entities (NCEs). We will molecular network mass spectrometry datasets collected from the cultivation of 12 myxobacteria using these conditions facilitated by the Global Natural Products Social Molecular Networking (GNPS) open access platform to efficiently identify resulting NCEs for further antimicrobial assessment. These molecular networking efforts will generate 1,008 datasets that will represent the chemical space available to myxobacteria when exposed to prey or isolated prey EPS and significantly benefit dereplication and discovery efforts. Our conservative expectation of 1-2 NCEs per investigated myxobacterial predator would provide a total of 13-26 potential antimicrobial NCEs upon completion of the proposed research.

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    P20
  • Administering IC
    GM
  • Application Type
    5
  • Direct Cost Amount
    175000
  • Indirect Cost Amount
    78534
  • Total Cost
  • Sub Project Total Cost
    253534
  • ARRA Funded
    False
  • CFDA Code
  • Ed Inst. Type
  • Funding ICs
    NIGMS:253534\
  • Funding Mechanism
    RESEARCH CENTERS
  • Study Section
    ZGM1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    UNIVERSITY OF MISSISSIPPI
  • Organization Department
  • Organization DUNS
    067713560
  • Organization City
    UNIVERSITY
  • Organization State
    MS
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    386771848
  • Organization District
    UNITED STATES